KMT2A fusion
Gene Variant Detail

Request Content

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Gene KMT2A
Variant fusion
Impact List fusion
Protein Effect unknown
Gene Variant Descriptions KMT2A fusion indicates a fusion of the KMT2A gene, but the fusion partner is unknown.
Associated Drug Resistance
Category Variants Paths

KMT2A mutant KMT2A rearrange KMT2A fusion

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

No Variant Reference Transcript is Available.
No transcript is Available.

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Clinical Trial Phase Therapies Title Recruitment Status Covered Countries Other Countries
NCT02487459 Phase I Rivogenlecleucel Rimiducid Safety Study of Gene Modified Donor T-Cells in Adults With Advanced Hematologic Malignancies Withdrawn USA 0
NCT07223814 Phase III Cytarabine + Daunorubicin Bleximenib + Cytarabine + Idarubicin Cytarabine + Idarubicin Bleximenib + Cytarabine + Daunorubicin Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML) Recruiting USA | NLD | DEU 0
NCT07355335 Phase I CC-92480 + Ziftomenib Ziftomenib + Mezigdomide in Adolesc. and Adults w/ R/R AML Not yet recruiting USA 0
NCT04988555 Phase Ib/II DSP-5336 DSP-5336 + Fluconazole Azacitidine + DSP-5336 + Venetoclax DSP-5336 + Gilteritinib Azacitidine + DSP-5336 + Fluconazole + Venetoclax A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1) Recruiting USA | ITA | GBR | FRA | ESP | CHE | CAN | BEL 4